BioNTech RNA vaccine candidate(s) for SARS-CoV-2 variants
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BioNTech RNA vaccine candidate(s) for SARS-CoV-2 variants, covering 2026-04-28 to 2026-04-28. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals [Phase 2, Phase 3]